List of Studies ( Metabolite:PC 13:1_16:1)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST003988 | AN006569 | Lipid and cell cycling perturbations driven by the HDAC inhibitor romidepsin render liver cancer vulnerable to RTK targeting and immunologically active | Cultured cells | Human | Cancer | CNRS | LC-MS |
| ST003452 | AN005668 | Integrated Proteomic and Lipidomic Analysis | Adipose tissue | Human | Obesity | Hamamatsu University School of Medicine | LC-MS |